Owlet, Inc. (OWLT)
NYSE: OWLT · IEX Real-Time Price · USD
4.470
-0.120 (-2.61%)
At close: Jul 19, 2024, 4:00 PM
4.610
+0.140 (3.13%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Company Description
Owlet, Inc. provides digital parenting solutions in the United States and internationally.
The company’s platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, activity, oxygen, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam.
The company was founded in 2012 and is headquartered in Lehi, Utah.
Owlet, Inc.
Country | United States |
Founded | 2013 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 76 |
CEO | Kurt Workman |
Contact Details
Address: 3300 North Ashton Boulevard, Suite 300 Lehi, Utah 84043 United States | |
Phone | (844) 334-5330 |
Website | owletcare.com |
Stock Details
Ticker Symbol | OWLT |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001816708 |
CUSIP Number | 69120X107 |
ISIN Number | US69120X2062 |
SIC Code | 3829 |
Key Executives
Name | Position |
---|---|
Kurt Workman | Co-Founder, Chief Executive Officer and Director |
Kathryn R. Scolnick | Chief Financial Officer and Principal Accounting Officer |
Jonathan Harris | President and Chief Revenue Officer |
David Kizer | Chief Operating Officer |
Burc Sahinoglu | Chief Technology Officer |
Albert Li | Chief Legal Officer and Corporate Secretary |
Elizabeth Teran | Chief Marketing Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 10, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jul 9, 2024 | 8-K | Current Report |
Jul 3, 2024 | ARS | Filing |
Jul 3, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jul 3, 2024 | DEF 14A | Other definitive proxy statements |
Jun 18, 2024 | 8-K | Current Report |
May 23, 2024 | 424B3 | Prospectus |
May 22, 2024 | EFFECT | Notice of Effectiveness |
May 20, 2024 | UPLOAD | Filing |
May 16, 2024 | 144 | Filing |